Life Science
Life Sciences
Life Sciences
View the event on LinkedIn, which was delivered live on Wednesday, February 21, 2024.
In the rapidly advancing field of clinical technology, pharma enterprises are faced with challenges such as fragmented data, compounded by interoperability issues and inefficiencies. There is a growing need for real-time insights and a unified data platform to enhance clinical decision-making, interoperability, and operational efficiency.
Watch this interactive LinkedIn Live session to explore how an end-to-end platform approach to clinical data and analytics can enable seamless data integration, improve data quality, accelerate trial timelines, and improve patient outcomes. Additionally, discover the evolving areas in clinical data and analytics and get a view of the outlook for this segment.
During this event, we dived into questions such as:
As life sciences enterprises adapt to the post-pandemic market, global macroeconomic uncertainties and geopolitical disruptions are compelling biopharmaceutical and medical devices enterprises to rethink their future growth strategy. These enterprises are rationalizing and restructuring their portfolios, strategically addressing high-priority quick-wins use cases for digital transformation, and actively seeking providers with greater domain knowledge, enhanced agility, and life sciences-specific technical expertise. Niche providers are emerging in the post-pandemic era and are establishing a strong presence in the digital services market.
In this report, we closely examine the life sciences digital services specialists state of the market while focusing on the following aspects:
Scope
The PEAK Matrix® provides an objective, data-driven assessment of service and technology providers based on their overall capability and market impact across different global services markets, classifying them into three categories: Leaders, Major Contenders, and Aspirants.
The payment integrity market is dynamically transforming, continuously adapting and enhancing fundamental capabilities within the healthcare industry. The growing emphasis on ensuring accurate and efficient payment processes is creating various opportunities. Key trends gaining prominence include advances in fraud detection and prevention technologies, using sophisticated data analytics for claims validation, integrating AI to identify irregularities, and implementing predictive modeling to forecast potential risks. The industry is experiencing a surge in collaborations and partnerships among payment integrity solution providers, healthcare organizations, and regulatory bodies to create robust ecosystems that foster innovation. Additionally, there is a notable shift toward leveraging next-generation technologies, such as generative AI, to enhance payment accuracy. This evolution underscores the industry’s commitment to refining payment integrity practices through technology innovation and strategic collaborations.
This report analyzes 18 payment integrity solutions providers and includes:
Scope
The PEAK Matrix® provides an objective, data-driven assessment of service and technology providers based on their overall capability and market impact across different global services markets, classifying them into three categories: Leaders, Major Contenders, and Aspirants.
Healthcare enterprises have made digital adoption the bedrock of their growth strategies to optimize processes, realize cost efficiencies, and enhance member experiences. They are leveraging digital services for value-based care and population health management and to comply with changing regulations. To support enterprises on their digital transformation journeys, providers are ramping up their capabilities through vertical-specific partnerships and acquisitions, investments in Centers of Excellence (CoEs), and training, among other things. These efforts are, in turn, driving the need for research and market intelligence on demand and supply trends in healthcare payer digital services.
This report comprises three sections:
Scope
The PEAK Matrix® provides an objective, data-driven assessment of service and technology providers based on their overall capability and market impact across different global services markets, classifying them into three categories: Leaders, Major Contenders, and Aspirants.
Decentralized Clinical Trials (DCTs) are transforming the landscape of clinical research by harnessing digital technologies to facilitate remote patient participation. This patient-centric approach not only benefits participants but also ensures more inclusive and robust study results while reducing the workload for investigators. In the post-pandemic climate, a hybrid model is emerging that seamlessly integrates technology advances with traditional site workflows, creating a new era of clinical trials that harnesses the strengths of both. In a funding-constrained environment, DCT platform providers are looking to strike a balance between client satisfaction and cost reduction. They are focusing on delivering comprehensive solutions that include real-world evidence, integration with sensors and wearables, and tools dedicated to enhancing patient engagement and retention throughout the trial process.
In this report, we:
Scope
The PEAK Matrix® provides an objective, data-driven assessment of service and technology providers based on their overall capability and market impact across different global services markets, classifying them into three categories: Leaders, Major Contenders, and Aspirants.
Life Science
Life Sciences
©2024 Everest Global, Inc. Privacy Notice Terms of Use Do Not Sell My Information Research Participation Terms
"*" indicates required fields